<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Sun Pharmaceutical Industries Limited

NSE: SUNPHARMA · Lot size: 350

OverviewOption ChainOI AnalysisFII / DIIMax Pain

Sun Pharmaceutical Industries Limited FII & DII Activity

FII Net (₹ Cr)
-1,059.93
Buy 12,756.88 · Sell 13,816.81
DII Net (₹ Cr)
+2,966.89
Buy 18,753.06 · Sell 15,786.17
FII F&O Net (contracts)
+0
Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-04-21-1,059.93+2,966.89
2026-04-20+683.2-4,721.48
2026-04-18+683.2-4,721.48
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

FIIs are net sellers in Sun Pharmaceutical Industries Limited today, offloading ₹1059.93 Cr in the cash segment, while DIIs counterbalance with strong inflows of ₹2966.89 Cr. This reflects divergent institutional sentiment, with domestic investors absorbing foreign outflows. Cash market activity shows DIIs asserting control amid FII profit-booking or portfolio rebalancing.

Trend vs 5-Day Average

Today’s FII outflow contrasts with their 5-day average inflow of ₹683.2 Cr, signaling a near-term shift in stance. Conversely, DII inflows reverse their own 5-day trend of average outflow (₹-4721.48 Cr), indicating renewed domestic appetite.

F&O Positioning Signal

FII F&O cash flow stands at ₹0 Cr, suggesting no directional derivatives bet on Sun Pharmaceutical Industries Limited today. However, the Index Futures Long/Short ratio of 1.2 hints at broader market optimism, potentially limiting downside pressure on large-cap stocks like Sun Pharma.

Implication for Finance

Sustained DII demand could support pharmaceutical sector stability tomorrow despite FII weakness.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21

Related Analysis

Same Sector

ABB
ABB India Limited
Neutral
ABCAPITAL
Aditya Birla Capital Limited
Neutral
ADANIENSOL
Adani Energy Solutions Limited
Neutral
ADANIENT
Adani Enterprises Limited
Neutral
ADANIGREEN
Adani Green Energy Limited
Neutral

Frequently Asked Questions

What is FII net buying/selling in Sun Pharmaceutical Industries Limited today?▾
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹1,059.93 Cr (net selling) as of 2026-04-21. This market-wide figure applies to all F&O stocks including Sun Pharmaceutical Industries Limited.
What is DII activity in Sun Pharmaceutical Industries Limited today?▾
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹2,966.89 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Sun Pharmaceutical Industries Limited today?▾
FII net F&O position (index + stock futures combined) is +0 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Sun Pharmaceutical Industries Limited?▾
Block deal data for Sun Pharmaceutical Industries Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Sun Pharmaceutical Industries Limited stock price?▾
FII and DII flows are market-wide data — all F&O stocks including Sun Pharmaceutical Industries Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Sun Pharmaceutical Industries Limited's individual OI buildup type, this provides a directional framework.